Observational studyMedicine2025
30 second screening test and education reduce chronic pain incidence after blood donation: Large prospective observational study from Japan.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venipuncture is a commonly performed procedure to obtain blood for testing or donation, but nerve injuries with persistent or chronic pain can occasionally occur. We implemented Phalen elbow flexion shoulder abduction (PEFSA) test to screen potential blood donors who may be at risk for persistent or chronic nerve pain after blood donation. Data were prospectively collected on all blood donors at Red Cross centers in Kansai area of Japan for 5 years prior to PEFSA test implementation, and then for 2 years after test implementation. Potential donors who had positive PEFSA test were given a handout informing them of potentially elevated risk for nerve complications. All donors who had persistent pain were followed and treated at Red Cross centers. There were 3,877,975 donors before and 1,461,965 potential donors after PEFSA test implementation. A total of 221 out of 15,776 potential donors with positive PEFSA test decided to stop donation. Prior to test implementation, 98 (0.00253%) donors developed persistent pain. Nineteen had symptoms lasting over 1 year. Six were diagnosed with complex regional pain syndrome (CRPS). After PEFSA test implementation, 22 (0.00151%) developed persistent pain. None had symptoms lasting >1 year or developed CRPS. Our data suggest that the PEFSA test alone do not identify high risk potential donors, but also educating the positive potential donors significantly decrease incidence of persistent pain and CRPS. To our knowledge, this study is the first to test an intervention that can help prevent persistent pain or CRPS from blood donation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.